Clinical Trial Update: Protocol for Post Marketing Surveillance of Actilyse Vial

View source ↗

Summary

This document outlines a protocol for post-marketing surveillance of Actilyse (alteplase) in stroke patients, and notes that the trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Actilyse (alteplase)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Stroke | Status: TERMINATED